Biscoumarin–pyrimidine conjugates as potent anticancer agents and binding mechanism of hit candidate with human serum albumin-Reference-Cited by-同舟云学术

Biscoumarin–pyrimidine conjugates as potent anticancer agents and binding mechanism of hit candidate with human serum albumin

Published:2020-09-18 Issue:1 Volume:354 Page:2000181
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch Pharm

Author:

Reddy Dinesh S.¹,Kongot Manasa¹,Singh Vishal²,Siddiquee Md. Abrar³,Patel Rajan³,Singhal Nitin K.²,Avecilla Fernando⁴,Kumar Amit¹^ORCID

Affiliation:

1. Centre for Nano and Material Sciences, Jain University, Jain Global Campus Bangalore India

2. National Agri Food Biotechnology Institute Mohali India

3. Biophysical Chemistry Laboratory, Centre for Interdisciplinary Research in Basic Sciences Jamia Millia Islamia (A Central University) New Delhi India

4. Departamento de Química, Facultade de Ciencias, Grupo Xenomar, Centro de Investigacións Científicas Avanzadas (CICA) Universidade da Coruña A Coruña Spain

Funder

Science and Engineering Research Board

Jain University

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.202000181

Reference59 articles.

1. Remaining Challenges in Childhood Cancer and Newer Targeted Therapeutics

2. TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy